Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nivolumab 100mg/10ml solution for infusion vials
0802040ATAAABAB
|
Nivolumab (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Nivolumab 240mg/24ml solution for infusion vials
0802040ATAAACAC
|
Nivolumab (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Nivolumab 40mg/4ml solution for infusion vials
0802040ATAAAAAA
|
Nivolumab (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.